🐦 Archived X post

A tamper-evident, on-chain timestamp of what this post said. Captured 2026-09-07 12:10 UTC.

@BioSignalon X · 2026-09-04
Teva bid for BioXcel's neuroscience assets on the same day BioXcel filed Chapter 11 in Delaware. $57.5 million upfront, up to $67.5 million in development milestones, and up to $20 million more tied to sales. Read the milestone structure, because that is the actual trade. The development payments are indexed to the outcome and the timing of one pending sNDA: at-home use of BXCL501, PDUFA date 14 November. Approve on schedule and the estate collects the top of the ladder. Slip, and the estate collects less for the same approval. I have not seen a bankruptcy auction price an FDA calendar this directly. Creditor recovery is now partly a function of whether the agency hits its own date. The asset itself is not a failure. Igalmi cleared in 2022 on two Phase 3s, dexmedetomidine sublingual film, a selective alpha-2 agonist that cut acute agitation within two hours. The problem was always the label. It has to be given under supervision by a healthcare professional, which confines an acute-agitation drug to the ER and the inpatient ward. Acute agitation mostly happens at home. BioXcel ran out of runway before it could reach the label that made the product make sense. $12.8 million in cash at the end of June against roughly $6 million a quarter in operating burn. Shares fell more than 70% to about nineteen cents. Teva closed a deal for Emalex in June worth up to $900 million. This is the same neuroscience pivot at a seventh of the headline, because this seller had no time left. One caveat worth holding. Teva is the stalking horse, not the buyer. The auction can still take it away from them. $TEVA $BTAI $XBI $IBB ✨ Made with AI
posthttps://x.com/BioSignal/status/2095882120900333898
author id1990225480168169472
posted2026-09-04T14:30:11.000Z
manifest sha256f11fa00c6a141a44544e6d430863f002f944af14ca57ac66eb4a189a2faf25e2
text sha2569ab20106beb4ffd35911c9842cfda577c095104609a1f8d1fc657d4d7af84290
on-chain⛓ anchored — f04fd84a92abe86b26ab3c8d3d842d42e4b5d659a00809f8b114334c81047abb

Verify it yourself: the manifest is the exact JSON whose SHA-256 is f11fa00c6a141a44544e6d430863f002f944af14ca57ac66eb4a189a2faf25e2; it binds the tweet id, author, post time, and the SHA-256 of the text above. Re-hash the text to match 9ab20106beb4ffd35911c9842cfda577c095104609a1f8d1fc657d4d7af84290, and read the anchor transaction's OP_RETURN bsv.cx / x1 / f11fa00c6a141a44544e6d430863f002f944af14ca57ac66eb4a189a2faf25e2 — the block's timestamp proves the post said this at or before that time, with no trust in bsv.cx. Content archived via the X API.

← bsv.cx · JSON · ⚠ Report